Results 111 to 120 of about 17,715 (228)

LVAD in situs viscerum inversus totalis.

, 2011
LVAD in situs viscerum inversus ...
LUCIANI, GIOVANNI BATTISTA, FAGGIAN, Giuseppe, Giuseppe Faggian, Alberto Forni, Giovanni Battista Luciani, FORNI, ALBERTO   +5 more
core   +1 more source

Impact on renal function in the transition from ventricular assist device to orthotopic cardiac transplant.

reservedIntroduzione: L'insufficienza cardiaca è una sindrome clinica complessa, caratterizzata da sintomi e segni che derivano da una compromissione strutturale o funzionale del riempimento ventricolare o della capacità di eiezione.
CUVA, GIANLUCA
core  

Being Unchosen for LVAD-DT [PDF]

The American Journal of Bioethics, 2017
Anjali R, Truitt, Francys C, Verdial
openaire   +2 more sources

Delayed closure of ventricular septal defect with prolonged mechanical support

European Journal of Case Reports in Internal Medicine
Introduction: Ventricular septal defect (VSD) is a severe complication following acute myocardial infarction (MI) resulting from mechanical disruption of the interventricular septum due to extensive myocardial necrosis.
Dawood Shehzad, Mustafa Shehzad, Muhammad Ahmad, Abdul Wassey, Noor Zara, Humna Younis, Haider Ali Babar Khan   +6 more
doaj   +1 more source

Fluid-mechanics Simulations of Ventricular Function under LVAD Support

, 2010
LVAD implantation is often used to assist patients suffering heart failure. These devices profoundly alter ventricular behaviour, however, the precise impact on the myocardium and on ventricular blood flow remains unknown.
Nordsletten, D, McCormick, M, Kay, D, Smith, NP, NP Smith, Vecchi, A., D. Kay, D. Nordsletten, Smith, P, Nordsletten, D., Kay, D., M. McCormick, McCormick, M., de Vecchi, A, A. Vecchi   +14 more
core   +1 more source

Evaluation of LVAD infections in a tertiary university hospital cohort

AIM: This study aims to evaluate driveline infections in ourcenter in terms of pathogens and resistance patterns. BACKGROUND: The use of left ventricular assist devices (LVAD) is increasing for bridging therapy inpatients who cannot undergo heart ...
Oğuzhan Acet, Çağatay Engin, Mustafa Özbaran, Derya Kaya, Meltem Taşbakan, Hasip Kahraman, Oğuz Reşat Sipahi, Ümit Kahraman, Muhammed Alper Özarslan, Tahir Yağdıç   +9 more
core   +1 more source

The LVAD caregiving journey: a systematic review and thematic synthesis

Background Left ventricular assist devices (LVADs) are an established therapy for advanced heart failure and require extensive involvement from informal caregivers. Despite their central role in everyday management and decision-making,
B Ben Avraham, M Liljeroos, M Eriksson-Liebon, T Jaarsma, T Ben Gal, N P Kato, A Stromberg   +6 more
core   +1 more source

ECG analysis during continuous-flow LVAD

, 2014
International audienceNowadays, left continuous-flow assist devices (LVAD) are used for the treatment of end-stage heart failure not only as bridge to transplantation but also as a destina- tion therapy.
Meste, Olivier, Ferrari, Gianfranco, Di Molfetta, Arianna, Bernini, Fabio, Trivella, Maria Giovanna, Cabasson, Aline, Fresiello, Libera   +6 more
core   +1 more source

Deactivation of LVAD support for myocardial recovery-surgical perspectives.

Left ventricular assist devices (LVADs) are excellent therapies for advanced heart failure patients either bridged to transplant or for lifetime use. LVADs also allow for reverse remodeling of the failing heart that is often associated with functional ...
Atluri, Pavan, MD, D\u27Alessandro, David, Faerber, Gloria, Tsukashita, Masaki, Goldstein, Daniel, Nickel, Ian, Potapov, Evgenij, Falk, Volkmar, Slaughter, Mark S, Sun, Benjamin, Zimpfer, Daniel, Lanmüller, Pia, Anyanwu, Anelechi, Koliopoulou, Antigone, Doenst, Torsten, Silvestry, Scott, Kirov, Hristo, Yarboro, Leora, Selzman, Craig H, Adachi, Iki, Milano, Carmelo, Bommareddi, Swaroop   +21 more
core   +1 more source

Clinical differences between destination therapy and bridge-to-transplant left ventricular assist device implantation: a 17-year single-center experience in Japan. [PDF]

J Artif Organs
Inoue K, Yoshioka D, Misumi Y, Kawamura A, Yajima S, Kawamura T, Saito S, Yamauchi T, Miyagawa S.   +8 more
europepmc   +1 more source